US medtech industry suggests improvements to FDA's proposed early advice programme
This article was originally published in SRA
Executive Summary
The US medtech industry says it welcomes the Food and Drug Administration's proposal to expand its existing programme on offering early advice to medical device manufacturers on product-specific applications, but it wants the agency to clarify how this may affect other early collaboration meetings between the FDA and device companies1,2.